- Title
- MP24-14 PEMBROLIZUMAB (PEMBRO) PLUS OLAPARIB IN PATIENTS WITH DOCETAXEL-PRETREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): UPDATED RESULTS FROM KEYNOTE-365 COHORT A WITH A MINIMUM OF 11 MONTHS OF FOLLOW-UP FOR ALL PATIENTS
- Creators
- Luke T. NordquistEvan Y. YuJosep M. PiulatsGwenaelle GravisPeter C.C. FongTilman TodenhoeferBrigitte LaguerreJose Angel Arranz ArijaStephane OudardChristophe Massardet al.
- Publication Details
- The Journal of urology, Vol.206(Supplement 3), pp.e417-e417
- Identifiers
- 991006262531802656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
MP24-14 PEMBROLIZUMAB (PEMBRO) PLUS OLAPARIB IN PATIENTS WITH DOCETAXEL-PRETREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): UPDATED RESULTS FROM KEYNOTE-365 COHORT A WITH A MINIMUM OF 11 MONTHS OF FOLLOW-UP FOR ALL PATIENTS
The Journal of urology, Vol.206(Supplement 3), pp.e417-e417
09/2021
Metrics
1 Record Views